The Deep Dive
Unfiltered insights on what’s new and next in media, culture, and the systems that govern us.
The Corporate Trip-Sitter: How Big Pharma is Gentrifying the Magic Mushroom
While the FDA plays willfully ignorant to stall natural psychedelic cures, Wall Street biotech bros are frantically racing to patent synthetic, "trip-less" mushrooms to keep your depression tethered to a monthly subscription.
